bilobalide has been researched along with warfarin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kubota, Y; Shinozuka, K; Taki, Y; Umegaki, K; Watanabe, Y; Yamada, S; Yokotani, K | 1 |
| Han, L; Qu, J; Qu, Q; Wu, LX; Zhan, M; Zhang, W; Zhang, YW; Zhou, HH | 1 |
2 other study(ies) available for bilobalide and warfarin
| Article | Year |
|---|---|
Ginkgo biloba extract attenuates warfarin-mediated anticoagulation through induction of hepatic cytochrome P450 enzymes by bilobalide in mice.
Topics: Animals; Anticoagulants; Blood Coagulation; Coagulants; Cyclopentanes; Cytochrome P-450 Enzyme System; Enzyme Induction; Furans; Ginkgo biloba; Ginkgolides; Herb-Drug Interactions; Lactones; Liver; Male; Mice; Mice, Inbred ICR; Plant Extracts; Warfarin | 2012 |
Inhibitory effects of phytochemicals on metabolic capabilities of CYP2D6(*)1 and CYP2D6(*)10 using cell-based models in vitro.
Topics: Berberine; Cell Line, Tumor; Chromatography, High Pressure Liquid; Coumarins; Cyclooctanes; Cyclopentanes; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Furans; Ginkgolides; Hep G2 Cells; Humans; Isoflavones; Kinetics; Lignans; Luteolin; Phytochemicals; Polycyclic Compounds | 2014 |